<?xml version="1.0" encoding="utf-8"?>
<!-- Generator: Adobe Illustrator 15.0.2, SVG Export Plug-In . SVG Version: 6.00 Build 0)  -->
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd">
<svg version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px"
	 width="841.889px" height="595.275px" viewBox="0 0 841.889 595.275" enable-background="new 0 0 841.889 595.275"
	 xml:space="preserve">
<rect x="3.819" y="311.421" opacity="0.12" width="515.763" height="281.801"/>
<g>
	<g>
		<line fill="none" stroke="#000000" stroke-width="0.7423" x1="220" y1="89.614" x2="230.116" y2="89.614"/>
		<path d="M234.595,89.614c-2.108,0.782-4.723,2.117-6.344,3.529l1.276-3.529l-1.276-3.529
			C229.872,87.497,232.487,88.832,234.595,89.614z"/>
	</g>
</g>
<g>
	<g>
		<line fill="none" stroke="#000000" stroke-width="0.7423" x1="159.595" y1="99.614" x2="231.584" y2="99.614"/>
		<path d="M236.064,99.614c-2.107,0.782-4.723,2.117-6.344,3.529l1.276-3.529l-1.276-3.529
			C231.341,97.497,233.957,98.832,236.064,99.614z"/>
	</g>
</g>
<rect x="16.918" y="34.28" fill="none" stroke="#000000" stroke-width="0.8008" width="455" height="135.437"/>
<rect x="546.469" y="34.148" fill="none" stroke="#000000" stroke-width="0.7501" width="252.531" height="99.852"/>
<g>
	<g>
		<line fill="none" stroke="#000000" x1="606.005" y1="335.287" x2="596.973" y2="353.358"/>
		<path d="M594.275,358.757c0.326-3.012,0.293-6.967-0.433-9.771l3.484,3.664l5.022,0.587
			C599.67,354.34,596.486,356.688,594.275,358.757z"/>
	</g>
</g>
<g>
	<g>
		<line fill="none" stroke="#000000" x1="654.672" y1="335.549" x2="654.005" y2="356.502"/>
		<path d="M653.813,362.534c-0.963-2.872-2.647-6.451-4.481-8.693l4.698,1.869l4.808-1.567
			C656.865,356.265,654.957,359.729,653.813,362.534z"/>
	</g>
</g>
<g>
	<g>
		<line fill="none" stroke="#000000" x1="701.339" y1="335.549" x2="766.005" y2="355.192"/>
		<path d="M771.779,356.946c-3.023,0.183-6.916,0.879-9.559,2.065l3.026-4.05l-0.263-5.049
			C766.52,352.368,769.368,355.113,771.779,356.946z"/>
	</g>
</g>
<rect x="562.67" y="356.369" fill="none" stroke="#000000" width="98.305" height="177.656"/>
<rect x="665.641" y="356.691" fill="none" stroke="#000000" width="68.666" height="178"/>
<rect x="739.006" y="356.616" fill="none" stroke="#000000" width="75.207" height="180.156"/>
<rect x="577.33" y="225.612" fill="none" stroke="#000000" stroke-width="0.4697" width="175.916" height="72.111"/>
<g>
	<g>
		<line fill="none" stroke="#000000" stroke-width="2" x1="644.885" y1="182.292" x2="644.885" y2="201.985"/>
		<g>
			<path d="M644.885,198.395l7.205-4.383l0.164,0.246l-4.668,11.75c-0.9,4.094-1.801,8.188-2.701,12.281
				c-0.902-4.094-1.801-8.188-2.703-12.281l-4.665-11.75l0.12-0.246L644.885,198.395z"/>
		</g>
	</g>
</g>
<line fill="none" stroke="#000000" x1="536.334" y1="34.999" x2="536.334" y2="595.275"/>
<rect fill="none" stroke="#000000" stroke-width="3" width="841.889" height="595.275"/>
<g>
	<g>
		<path d="M130.958,213.68c22.112-0.184,44.193,1.118,66.292,1.671c10.408,0.26,20.854,0.381,31.258-0.09
			c10.478-0.474,20.597-3.727,31.117-3.915c0.549-0.01,2.108-0.858,0.821-0.835c-9.883,0.177-19.446,2.79-29.246,3.775
			c-11.417,1.148-23.206,0.467-34.66,0.18c-21.59-0.54-43.156-1.801-64.761-1.622C131.228,212.85,129.67,213.691,130.958,213.68
			L130.958,213.68z"/>
	</g>
</g>
<g>
	<g>
		<path d="M131.909,225.821c10.435-1.859,20.633,1.962,30.975,2.837c10.647,0.9,21.758,0.403,32.381-0.675
			c21.532-2.185,42.684-10.195,64.516-6.178c0.641,0.118,2.285-0.879,1.174-1.084c-20.877-3.841-41.486,2.834-62.034,5.728
			c-11.563,1.629-23.657,1.853-35.297,1.071c-10.598-0.711-20.757-4.723-31.464-2.815
			C131.229,224.871,130.581,226.058,131.909,225.821L131.909,225.821z"/>
	</g>
</g>
<g>
	<g>
		<path d="M130.91,233.644c19.8,3.737,39.938,6.07,60.1,4.612c23.021-1.664,45.155-8.762,68.401-8.922
			c0.416-0.003,2.204-0.815,1.248-0.809c-20.418,0.142-40.124,4.874-60.196,7.97c-22.483,3.468-45.795,0.571-67.969-3.614
			C132.031,232.794,130.353,233.539,130.91,233.644L130.91,233.644z"/>
	</g>
</g>
<g>
	<g>
		<path d="M261.117,230.542c-42.664,5.727-86.136,18.271-128.86,6.06c-0.846-0.242-2.284,0.986-1.11,1.321
			c43.094,12.317,86.759-0.163,129.806-5.94C262.027,231.838,262.429,230.367,261.117,230.542L261.117,230.542z"/>
	</g>
</g>
<g>
	<g>
		<path d="M133.063,253.586c20.586-7.636,42.463,1.533,63.61,0.814c10.593-0.36,21.133,0.685,31.695,0.245
			c5.161-0.215,10.303-0.894,15.448-1.324c5.758-0.481,11.494-0.015,17.248-0.319c0.622-0.033,2.08-1.031,0.787-0.963
			c-5.753,0.304-11.488-0.091-17.249,0.319c-5.802,0.413-11.568,1.162-17.385,1.404c-5.578,0.232-11.151-0.508-16.72-0.721
			c-5.58-0.213-11.189,0.385-16.767,0.495c-20.827,0.41-40.942-8.183-61.391-0.598C131.062,253.414,132.249,253.888,133.063,253.586
			L133.063,253.586z"/>
	</g>
</g>
<g>
	<g>
		<path d="M134.105,265.192c21.022-6.143,42.761,2.032,64.079,1.825c20.963-0.203,41.795-3.146,62.75-3.621
			c0.372-0.008,2.184-0.759,1.267-0.738c-22.229,0.505-44.317,3.607-66.563,3.643c-20.82,0.034-40.995-7.677-61.674-1.635
			C132.856,264.99,132.989,265.519,134.105,265.192L134.105,265.192z"/>
	</g>
</g>
<g>
	<g>
		<path fill="#E2001A" d="M259.854,270.378c-20.925-0.263-41.765,1.615-62.618,3.088c-10.368,0.732-20.745,1.293-31.139,1.438
			c-11.032,0.154-21.626-1.308-32.393-3.67c-0.939-0.206-1.951,1.108-0.673,1.389c9.586,2.104,19.184,3.657,29,3.699
			c11.038,0.047,22.072-0.583,33.08-1.324c21.51-1.448,42.983-3.495,64.566-3.223C260.777,271.79,261.163,270.395,259.854,270.378
			L259.854,270.378z"/>
	</g>
</g>
<g>
	<g>
		<path fill="#E2001A" d="M133.255,277.691c16.454,6.395,28.808,21.645,47.963,16.443c4.988-1.354,9.788-3.463,14.614-5.287
			c7.75-2.928,15.396-4.334,23.668-4.683c13.832-0.583,27.662,1.419,41.485,1.68c0.639,0.012,2.087-0.938,0.787-0.963
			c-12.551-0.237-25.043-1.698-37.6-1.749c-10.767-0.044-20.603,1.873-30.639,5.664c-6.258,2.364-12.517,5.267-19.282,5.664
			c-5.141,0.302-10.11-1.488-14.651-3.704c-8.564-4.178-15.838-10.444-24.788-13.923
			C134.302,276.635,132.537,277.412,133.255,277.691L133.255,277.691z"/>
	</g>
</g>
<g>
	<g>
		<path fill="#E2001A" d="M146.939,278.6c6.625-0.524,13.137,1.5,19.531,2.954c0.784,0.178,2.291-0.985,1.13-1.249
			c-6.707-1.524-13.52-3.596-20.469-3.046C146.072,277.342,145.617,278.705,146.939,278.6L146.939,278.6z"/>
	</g>
</g>
<g>
	<g>
		<path fill="#E2001A" d="M167.125,283.592c7.45,3.327,15.704,2.146,23.618,2.066c0.404-0.004,2.199-0.801,1.252-0.791
			c-7.693,0.078-15.803,1.302-23.049-1.934C168.423,282.7,166.913,283.498,167.125,283.592L167.125,283.592z"/>
	</g>
</g>
<g>
	<g>
		<path fill="#E2001A" d="M184.151,280.362c9.945-3.028,20.792-1.657,30.95-0.61c0.55,0.057,2.263-0.869,1.202-0.979
			c-10.667-1.1-21.945-2.457-32.384,0.723C182.788,279.84,183.005,280.711,184.151,280.362L184.151,280.362z"/>
	</g>
</g>
<g>
	<g>
		<path fill="#E2001A" d="M219.585,280.011c8.048,1.757,16.389,0.652,24.333,3c0.502,0.148,2.24-0.632,1.565-0.831
			c-7.958-2.352-16.28-1.242-24.333-3C220.643,279.069,218.931,279.868,219.585,280.011L219.585,280.011z"/>
	</g>
</g>
<g>
	<g>
		<path fill="#E2001A" d="M240.987,278.289c5.521-3.284,12.502-0.162,18.258,0.919c0.713,0.134,2.29-0.955,1.151-1.169
			c-6.813-1.279-14.142-4.339-20.646-0.469C238.625,278.239,240.281,278.708,240.987,278.289L240.987,278.289z"/>
	</g>
</g>
<g>
	<g>
		<path fill="#E2001A" d="M256.103,282.424c1.667,0.271,3.325,0.585,4.986,0.889c0.449,0.083,1.016-0.076,1.366-0.366
			c0.311-0.256,0.221-0.554-0.167-0.625c-1.661-0.304-3.319-0.618-4.986-0.889c-0.454-0.074-1.01,0.072-1.366,0.366
			C255.63,282.052,255.708,282.36,256.103,282.424L256.103,282.424z"/>
	</g>
</g>
<g>
	<g>
		<path fill="#E2001A" d="M178.098,276.292c-3.897,2.057-7.881,3.6-12.358,3.406c-0.754-0.033-2.051,1.073-0.742,1.13
			c5.169,0.224,9.802-1.55,14.309-3.928C180.457,276.292,178.747,275.95,178.098,276.292L178.098,276.292z"/>
	</g>
</g>
<g>
	<g>
		<path fill="#E2001A" d="M168.412,289.053c-6.345-0.239-12.283-3.752-17.607-6.921c-0.537-0.319-2.323,0.462-1.539,0.929
			c5.594,3.329,11.729,6.827,18.393,7.079C168.381,290.166,169.719,289.102,168.412,289.053L168.412,289.053z"/>
	</g>
</g>
<line fill="none" stroke="#E2001A" stroke-miterlimit="10" x1="131.368" y1="213.263" x2="131.368" y2="281.096"/>
<line fill="none" stroke="#E2001A" stroke-miterlimit="10" x1="260.368" y1="209.263" x2="260.368" y2="291.596"/>
<g>
	<g>
		<g>
			<polygon fill="#E2001A" points="144.369,220.065 157.459,213.979 146.889,216.452 144.369,200.763 141.85,216.452 
				131.277,213.979 			"/>
		</g>
	</g>
</g>
<g>
	<g>
		<g>
			<polygon fill="#E2001A" points="160.202,229.929 173.292,221.246 162.722,224.773 160.202,202.387 157.683,224.773 
				147.11,221.246 			"/>
		</g>
	</g>
</g>
<g>
	<g>
		<g>
			<polygon fill="#E2001A" points="177.036,239.096 190.125,227.273 179.555,232.076 177.036,201.596 174.516,232.076 
				163.944,227.273 			"/>
		</g>
	</g>
</g>
<g>
	<g>
		<g>
			<polygon fill="#E2001A" points="195.703,243.763 208.792,230.468 198.222,235.869 195.703,201.596 193.183,235.869 
				182.611,230.468 			"/>
		</g>
	</g>
</g>
<g>
	<g>
		<g>
			<polygon fill="#E2001A" points="215.703,247.179 228.792,233.057 218.222,238.794 215.703,202.388 213.183,238.794 
				202.611,233.057 			"/>
		</g>
	</g>
</g>
<g>
	<g>
		<g>
			<polygon fill="#E2001A" points="239.869,253.257 252.959,237.344 242.389,243.809 239.869,202.783 237.35,243.809 
				226.777,237.344 			"/>
		</g>
	</g>
</g>
<rect x="676.627" y="571.628" fill="none" width="144.773" height="16.731"/>
<text transform="matrix(1 0 0 1 676.627 580.1475)" fill="#009036" font-family="'MyriadPro-Regular'" font-size="12">Written by Dr Sebastian Zeki</text>
<rect x="548.333" y="122" fill="none" width="248.333" height="11.285"/>
<text transform="matrix(1 0 0 1 548.333 127.6797)" font-family="'MyriadPro-Regular'" font-size="8">All submucosal tumors have a substantial risk of lymph node metastases.</text>
<rect x="264.035" y="209.801" fill="none" width="37.167" height="10.89"/>
<text transform="matrix(1 0 0 1 264.0347 215.4805)" font-family="'MyriadPro-Regular'" font-size="8">Epithelium</text>
<rect x="264.035" y="221.596" fill="none" width="51.833" height="10.47"/>
<text transform="matrix(1 0 0 1 264.0347 227.2754)" font-family="'MyriadPro-Regular'" font-size="8">Lamina propria</text>
<rect x="263.202" y="229.429" fill="none" width="63.667" height="8.647"/>
<text transform="matrix(1 0 0 1 263.2017 235.1094)" font-family="'MyriadPro-Regular'" font-size="8">Muscularis mucosa</text>
<rect x="262.701" y="240.763" fill="none" width="41.5" height="8.647"/>
<text transform="matrix(1 0 0 1 262.7012 246.4424)" font-family="'MyriadPro-Regular'" font-size="8">Submucosa</text>
<rect x="138.702" y="190.262" fill="none" width="17" height="12.125"/>
<text transform="matrix(1 0 0 1 138.7017 198.7822)" font-family="'MyriadPro-Regular'" font-size="12">M1</text>
<rect x="154.035" y="190.262" fill="none" width="20.667" height="12.125"/>
<text transform="matrix(1 0 0 1 154.0347 198.7817)" font-family="'MyriadPro-Regular'" font-size="12">M2</text>
<rect x="169.368" y="190.262" fill="none" width="18" height="12.323"/>
<text transform="matrix(1 0 0 1 169.3682 198.7822)" font-family="'MyriadPro-Regular'" font-size="12">M3</text>
<rect x="184.702" y="190.262" fill="none" width="22" height="12.521"/>
<text transform="matrix(1 0 0 1 184.7017 198.7817)" font-family="'MyriadPro-Regular'" font-size="12">SM1</text>
<rect x="207.035" y="190.262" fill="none" width="23.667" height="12.521"/>
<text transform="matrix(1 0 0 1 207.0347 198.7822)" font-family="'MyriadPro-Regular'" font-size="12">SM2</text>
<rect x="230.368" y="190.262" fill="none" width="23.333" height="12.521"/>
<text transform="matrix(1 0 0 1 230.3682 198.7822)" font-family="'MyriadPro-Regular'" font-size="12">SM3</text>
<rect x="7.596" y="449.054" fill="none" width="175.878" height="146.563"/>
<text transform="matrix(1 0 0 1 7.5957 454.7334)"><tspan x="0" y="0" fill="#E2001A" font-family="'MyriadPro-BoldIt'" font-size="8">Endoscopic mucosal resection</tspan><tspan x="0" y="9.601" font-family="'MyriadPro-Regular'" font-size="8">5yr survival 96.6 %.</tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">Salvage surgery was needed in 3.7 %.</tspan><tspan x="0" y="28.8" font-family="'MyriadPro-Regular'" font-size="8">Complications of EMR include acute perforations </tspan><tspan x="0" y="38.4" font-family="'MyriadPro-Regular'" font-size="8">and bleeding (15%) and delayed esophageal </tspan><tspan x="0" y="48" font-family="'MyriadPro-Regular'" font-size="8">strictures.</tspan><tspan x="0" y="57.601" font-family="'MyriadPro-Regular'" font-size="8">22 % recurrence rate- can often be salvaged with </tspan><tspan x="0" y="67.2" font-family="'MyriadPro-Regular'" font-size="8">repeat EMR</tspan><tspan x="0" y="76.8" font-family="'MyriadPro-BoldIt'" font-size="8">EMR versus surgery</tspan><tspan x="0" y="86.4" font-family="'MyriadPro-Regular'" font-size="8">Survival rates were the same after EMR and </tspan><tspan x="0" y="96" font-family="'MyriadPro-Regular'" font-size="8">esophagectomy for superficial oesophageal cancer</tspan><tspan x="0" y="105.601" font-family="'MyriadPro-BoldIt'" font-size="8">Lesions&gt;2cm</tspan><tspan x="0" y="115.2" font-family="'MyriadPro-Regular'" font-size="8">1. Can use ESD</tspan><tspan x="0" y="124.8" font-family="'MyriadPro-Regular'" font-size="8">2. EMR plus PDT</tspan><tspan x="0" y="134.4" font-family="'MyriadPro-Regular'" font-size="8">May allow treatment of larger lesions.</tspan></text>
<rect x="189.762" y="450.848" fill="none" width="179.377" height="87.151"/>
<text transform="matrix(1 0 0 1 189.7622 456.5273)"><tspan x="0" y="0" fill="#E2001A" font-family="'MyriadPro-BoldIt'" font-size="8">Photodynamic therapy</tspan><tspan x="0" y="9.601" font-family="'MyriadPro-Regular'" font-size="8">Photosensitizing agent injected then light used to </tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">induce a nonthermal phototoxic reaction </tspan><tspan x="0" y="28.8" font-family="'MyriadPro-Regular'" font-size="8">(</tspan><tspan x="2.272" y="28.8" font-family="'MyriadPro-Regular'" font-size="8">5-aminolevulinic acid-5-ALA or photofrin</tspan><tspan x="0" y="38.4" font-family="'MyriadPro-BoldIt'" font-size="8">Role:</tspan><tspan x="17.344" y="38.4" font-family="'MyriadPro-Regular'" font-size="8"> </tspan><tspan x="0" y="48" font-family="'MyriadPro-Regular'" font-size="8">HGD in patients with Barrett&apos;s esophagus.</tspan><tspan x="0" y="57.601" font-family="'MyriadPro-Regular'" font-size="8">Large early cancers in the setting of extensive </tspan><tspan x="0" y="67.2" font-family="'MyriadPro-Regular'" font-size="8">Barrett&apos;s who are poor surgical candidates.</tspan><tspan x="0" y="76.8" font-family="'MyriadPro-Regular'" font-size="8">Small tumors are better treated with EMR.</tspan></text>
<rect x="7.596" y="346.912" fill="none" width="152.711" height="96.773"/>
<text transform="matrix(1 0 0 1 7.5957 352.5918)"><tspan x="0" y="0" fill="#E2001A" font-family="'MyriadPro-BoldIt'" font-size="8">Laser ablation</tspan><tspan x="0" y="9.601" font-family="'MyriadPro-Regular'" font-size="8">3 lasers- each have a different wavelength </tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">and therefore penetration:</tspan><tspan x="0" y="28.8" font-family="'MyriadPro-Regular'" font-size="8">* Neodynium:yttrium-aluminum-garnet </tspan><tspan x="0" y="38.4" font-family="'MyriadPro-Regular'" font-size="8">(Nd:YAG) 1064 nm, depth of penetration 4 </tspan><tspan x="0" y="48" font-family="'MyriadPro-Regular'" font-size="8">mm</tspan><tspan x="0" y="57.601" font-family="'MyriadPro-Regular'" font-size="8">* Potassium titanyl phosphate 532 nm, depth </tspan><tspan x="0" y="67.2" font-family="'MyriadPro-Regular'" font-size="8">of penetration 1 mm</tspan><tspan x="0" y="76.8" font-family="'MyriadPro-Regular'" font-size="8">* Argon 514.5 nm, depth of penetration 1 mm</tspan><tspan x="0" y="86.4" font-family="'MyriadPro-BoldIt'" font-size="8">Role:</tspan><tspan x="17.344" y="86.4" font-family="'MyriadPro-Regular'" font-size="8"> Uncertain</tspan></text>
<rect x="364.429" y="449.504" fill="none" width="103.212" height="38.885"/>
<text transform="matrix(1 0 0 1 364.4287 455.1836)"><tspan x="0" y="0" fill="#E2001A" font-family="'MyriadPro-BoldIt'" font-size="8">Argon plasma coagulation.</tspan><tspan x="0" y="9.601" font-family="'MyriadPro-Regular'" font-size="8">The depth of necrosis can </tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">reach up to 6 mm.</tspan><tspan x="0" y="28.8" font-family="'MyriadPro-BoldIt'" font-size="8">Role:</tspan><tspan x="17.344" y="28.8" font-family="'MyriadPro-Regular'" font-size="8"> Uncertain</tspan></text>
<rect x="364.429" y="344.515" fill="none" width="154.237" height="58.245"/>
<text transform="matrix(1 0 0 1 364.4287 350.1943)"><tspan x="0" y="0" fill="#E2001A" font-family="'MyriadPro-BoldIt'" font-size="8">Radiation With Or Without Chemotherapy</tspan><tspan x="0" y="9.601" font-family="'MyriadPro-Regular'" font-size="8">External and internal (brachytherapy) </tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">radiotherapy with or without concurrent </tspan><tspan x="0" y="28.8" font-family="'MyriadPro-Regular'" font-size="8">chemoradiotherapy are potentially useful </tspan><tspan x="0" y="38.4" font-family="'MyriadPro-BoldIt'" font-size="8">Role:</tspan><tspan x="17.344" y="38.4" font-family="'MyriadPro-Regular'" font-size="8">  Varices, in whom EMR and/or PDT are </tspan><tspan x="0" y="48" font-family="'MyriadPro-Regular'" font-size="8">contraindicated</tspan></text>
<rect x="189.762" y="344.915" fill="none" width="88.545" height="29.229"/>
<text transform="matrix(1 0 0 1 189.7622 350.5947)"><tspan x="0" y="0" fill="#E2001A" font-family="'MyriadPro-BoldIt'" font-size="8">Radiofrequency ablation</tspan><tspan x="0" y="9.601" font-family="'MyriadPro-Regular'" font-size="8">Halo system. </tspan><tspan x="0" y="19.2" font-family="'MyriadPro-BoldIt'" font-size="8">Role: </tspan><tspan x="18.816" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">HGD and IMC</tspan></text>
<rect x="196.035" y="321.427" fill="none" width="123.965" height="19.665"/>
<text transform="matrix(1 0 0 1 196.0347 331.3662)" fill="#E2001A" font-family="'MyriadPro-BoldIt'" font-size="14">Endoscopic Therapy</text>
<rect x="22.64" y="211.885" fill="none" width="97.254" height="69.586"/>
<text transform="matrix(1 0 0 1 22.6401 217.5654)"><tspan x="0" y="0" font-family="'MyriadPro-Regular'" font-size="8">M1 and M2 and </tspan><tspan x="0" y="9.6" font-family="'MyriadPro-Regular'" font-size="8">well-differentiated M3 </tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">disease without lymphatic </tspan><tspan x="0" y="28.8" font-family="'MyriadPro-Regular'" font-size="8">invasion,EMR is a good </tspan><tspan x="0" y="38.4" font-family="'MyriadPro-Regular'" font-size="8">second best to surgery </tspan><tspan x="0" y="48" font-family="'MyriadPro-Regular'" font-size="8">especially if patient not fit </tspan><tspan x="0" y="57.6" font-family="'MyriadPro-Regular'" font-size="8">enough</tspan></text>
<rect x="659.297" y="185.87" fill="none" width="81.01" height="29.125"/>
<text transform="matrix(1 0 0 1 659.2969 191.5498)"><tspan x="0" y="0" font-family="'MyriadPro-BoldIt'" font-size="8">For submucosal cancer, </tspan><tspan x="0" y="9.6" font-family="'MyriadPro-BoldIt'" font-size="8">oesophagectomy is </tspan><tspan x="0" y="19.2" font-family="'MyriadPro-BoldIt'" font-size="8">better than EMR</tspan></text>
<rect x="744.005" y="364.62" fill="none" width="70.208" height="173.658"/>
<text transform="matrix(1 0 0 1 744.0049 370.2998)"><tspan x="0" y="0" font-family="'MyriadPro-BoldIt'" font-size="8">Limited esophagec</tspan><tspan x="64.718" y="0" font-family="'MyriadPro-BoldIt'" font-size="8">-</tspan><tspan x="0" y="9.601" font-family="'MyriadPro-BoldIt'" font-size="8">tomy</tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">For a small subset of </tspan><tspan x="0" y="28.8" font-family="'MyriadPro-Regular'" font-size="8">patients with small </tspan><tspan x="0" y="38.4" font-family="'MyriadPro-Regular'" font-size="8">very early cancers </tspan><tspan x="0" y="48" font-family="'MyriadPro-Regular'" font-size="8">right at the GEJ, a </tspan><tspan x="0" y="57.601" font-family="'MyriadPro-Regular'" font-size="8">limited resection of </tspan><tspan x="0" y="67.2" font-family="'MyriadPro-Regular'" font-size="8">the distal esophagus </tspan><tspan x="0" y="76.8" font-family="'MyriadPro-Regular'" font-size="8">and proximal </tspan><tspan x="0" y="86.4" font-family="'MyriadPro-Regular'" font-size="8">stomach with jejunal </tspan><tspan x="0" y="96" font-family="'MyriadPro-Regular'" font-size="8">interposition and a </tspan><tspan x="0" y="105.601" font-family="'MyriadPro-Regular'" font-size="8">regional lymphad</tspan><tspan x="58.925" y="105.601" font-family="'MyriadPro-Regular'" font-size="8">-</tspan><tspan x="0" y="115.2" font-family="'MyriadPro-Regular'" font-size="8">enectomy can be </tspan><tspan x="0" y="124.8" font-family="'MyriadPro-Regular'" font-size="8">used.</tspan><tspan x="0" y="134.4" font-family="'MyriadPro-Regular'" font-size="8">Almost never done </tspan><tspan x="0" y="144" font-family="'MyriadPro-Regular'" font-size="8">as it is tricky and </tspan><tspan x="0" y="153.601" font-family="'MyriadPro-Regular'" font-size="8">often need </tspan><tspan x="0" y="163.2" font-family="'MyriadPro-Regular'" font-size="8">re-intervention</tspan></text>
<rect x="568.669" y="361.373" fill="none" width="93.638" height="127.17"/>
<text transform="matrix(1 0 0 1 568.6689 367.0527)"><tspan x="0" y="0" font-family="'MyriadPro-BoldIt'" font-size="8">Vagal-sparing esophagec</tspan><tspan x="87.878" y="0" font-family="'MyriadPro-BoldIt'" font-size="8">-</tspan><tspan x="0" y="9.601" font-family="'MyriadPro-BoldIt'" font-size="8">tomy</tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">Vagal-sparing esophagec</tspan><tspan x="84.141" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">-</tspan><tspan x="0" y="28.8" font-family="'MyriadPro-Regular'" font-size="8">tomy, is preferred over </tspan><tspan x="0" y="38.4" font-family="'MyriadPro-Regular'" font-size="8">radical esophagectomy in </tspan><tspan x="0" y="48" font-family="'MyriadPro-Regular'" font-size="8">those with intramucosal </tspan><tspan x="0" y="57.601" font-family="'MyriadPro-Regular'" font-size="8">cancer as low rate of nodal </tspan><tspan x="0" y="67.2" font-family="'MyriadPro-Regular'" font-size="8">mets</tspan><tspan x="0" y="76.8" font-family="'MyriadPro-Regular'" font-size="8">Oncological outcomes </tspan><tspan x="0" y="86.4" font-family="'MyriadPro-Regular'" font-size="8">similar to transhiatal/ </tspan><tspan x="0" y="96" font-family="'MyriadPro-Regular'" font-size="8">en-bloc resection for </tspan><tspan x="0" y="105.601" font-family="'MyriadPro-Regular'" font-size="8">superficial cancer and less </tspan><tspan x="0" y="115.2" font-family="'MyriadPro-Regular'" font-size="8">psot-op problems</tspan></text>
<rect x="670.004" y="361.287" fill="none" width="63.635" height="79.207"/>
<text transform="matrix(1 0 0 1 670.0039 366.9668)"><tspan x="0" y="0" font-family="'MyriadPro-BoldIt'" font-size="8">Minimally </tspan><tspan x="0" y="9.601" font-family="'MyriadPro-BoldIt'" font-size="8">invasive </tspan><tspan x="0" y="19.2" font-family="'MyriadPro-BoldIt'" font-size="8">esophagectomy</tspan><tspan x="0" y="28.8" font-family="'MyriadPro-Regular'" font-size="8">Better post op </tspan><tspan x="0" y="38.4" font-family="'MyriadPro-Regular'" font-size="8">recovery but </tspan><tspan x="0" y="48" font-family="'MyriadPro-Regular'" font-size="8">controversy </tspan><tspan x="0" y="57.601" font-family="'MyriadPro-Regular'" font-size="8">regarding </tspan><tspan x="0" y="67.2" font-family="'MyriadPro-Regular'" font-size="8">resection margins</tspan></text>
<rect x="579.005" y="313.615" fill="none" width="146.995" height="19.078"/>
<text transform="matrix(1 0 0 1 579.0049 323.5547)" fill="#E2001A" font-family="'MyriadPro-BoldIt'" font-size="14">Less radical approaches</text>
<rect x="581.668" y="228.988" fill="none" width="168.584" height="69.587"/>
<text transform="matrix(1 0 0 1 581.668 234.668)"><tspan x="0" y="0" font-family="'MyriadPro-BoldIt'" font-size="8">Oesophagectomy Outcomes</tspan><tspan x="0" y="9.6" font-family="'MyriadPro-Regular'" font-size="8">Recurrence rate 6 % </tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">Disease-specific five-year survival rate 100 % for </tspan><tspan x="0" y="28.8" font-family="'MyriadPro-Regular'" font-size="8">superficial cancer</tspan><tspan x="0" y="38.4" font-family="'MyriadPro-Regular'" font-size="8">Esophagectomy is frequently associated with </tspan><tspan x="0" y="48" font-family="'MyriadPro-Regular'" font-size="8">long-term problems such as dysphagia, weight </tspan><tspan x="0" y="57.6" font-family="'MyriadPro-Regular'" font-size="8">loss, gastroesophageal reflux, and dumping.</tspan></text>
<rect x="548.774" y="45.114" fill="none" width="250.226" height="77.757"/>
<text transform="matrix(1 0 0 1 548.7744 55.0537)"><tspan x="0" y="0" fill="#E2001A" font-family="'MyriadPro-BoldIt'" font-size="14">Submucosal superficial cancer types:</tspan><tspan x="0" y="24" font-family="'MyriadPro-Regular'" font-size="8">SM1 which penetrates the shallowest one-third of the submucosa.</tspan><tspan x="0" y="33.6" font-family="'MyriadPro-Regular'" font-size="8">SM2 which penetrates into the intermediate 1/3rd of the submucosa.</tspan><tspan x="0" y="43.2" font-family="'MyriadPro-Regular'" font-size="8">SM3 which penetrates the deepest one-third of the submucosa.</tspan><tspan x="0" y="52.8" font-family="'MyriadPro-Regular'" font-size="8">All SM categories are considered T1b disease according to the AJCC stage </tspan><tspan x="0" y="62.4" font-family="'MyriadPro-Regular'" font-size="8">definitions.</tspan></text>
<rect x="331.868" y="194.929" fill="none" width="192.714" height="103.079"/>
<text transform="matrix(1 0 0 1 331.8682 204.8691)"><tspan x="0" y="0" fill="#E2001A" font-family="'MyriadPro-BoldIt'" font-size="14">Assessment of Nodal Mets </tspan><tspan x="0" y="9.6" font-family="'MyriadPro-Regular'" font-size="8">Nodal metastasis rates higher than for SCC.</tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">Nodal met rates higher for non-flat lesions, but no </tspan><tspan x="0" y="28.8" font-family="'MyriadPro-Regular'" font-size="8">difference for poorly vs well differentiated.</tspan><tspan x="0" y="38.4" font-family="'MyriadPro-Regular'" font-size="8">EUS is the most accurate noninvasive method to assess </tspan><tspan x="0" y="48" font-family="'MyriadPro-Regular'" font-size="8">depth of invasion.</tspan><tspan x="0" y="67.2" font-family="'MyriadPro-Regular'" font-size="8">Conventional EUS cant distinguish subtypes of T1 lesions.</tspan><tspan x="0" y="76.8" font-family="'MyriadPro-Regular'" font-size="8">High-frequency EUS catheters good for T1 subtyping but </tspan><tspan x="0" y="86.4" font-family="'MyriadPro-Regular'" font-size="8">not for nodal staging.</tspan></text>
<rect x="216.418" y="80.947" fill="none" width="6.667" height="22.011"/>
<text transform="matrix(1 0 0 1 216.4185 93.7266)" font-family="'MyriadPro-Regular'" font-size="18">)</text>
<rect x="244.702" y="45.114" fill="none" width="221.883" height="74.42"/>
<text transform="matrix(1 0 0 1 244.7017 55.0537)"><tspan x="0" y="0" fill="#E2001A" font-family="'MyriadPro-BoldIt'" font-size="14">Risk of Mets with Mucosal Lesions</tspan><tspan x="0" y="9.6" font-family="'MyriadPro-Regular'" font-size="8">M1 and M2 tumors are not associated with lymph node metasta</tspan><tspan x="212.14" y="9.6" font-family="'MyriadPro-Regular'" font-size="8">-</tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">ses and so can be treated endoscopically.</tspan><tspan x="0" y="38.4" font-family="'MyriadPro-Regular'" font-size="8">The risk of nodal metastases with M3 tumors is as high as 12 %.</tspan><tspan x="0" y="57.6" font-family="'MyriadPro-Regular'" font-size="8">If any evidence of lymphatic invasion, very likely to have LN mets.</tspan></text>
<rect x="26.089" y="43.822" fill="none" width="197.277" height="128.689"/>
<text transform="matrix(1 0 0 1 26.0894 52.3418)"><tspan x="0" y="0" fill="#E2001A" font-family="'MyriadPro-BoldIt'" font-size="12">Mucosal superficial cancer</tspan><tspan x="0" y="9.6" font-family="'MyriadPro-Regular'" font-size="8">Early oesophageal cancers are defined as in situ lesions </tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">(Tis) or T1 tumors, which are split into T1a and T1b </tspan><tspan x="0" y="28.8" font-family="'MyriadPro-Regular'" font-size="8">subcategories depending on the depth of invasion.</tspan><tspan x="0" y="38.4" font-family="'MyriadPro-Regular'" font-size="8">More comprehensive subclassification divides into 3 types </tspan><tspan x="0" y="48" font-family="'MyriadPro-Regular'" font-size="8">based upon the depth of invasion. </tspan><tspan x="0" y="67.2" font-family="'MyriadPro-Regular'" font-size="8">M1 is limited to the epithelial layer.</tspan><tspan x="0" y="76.8" font-family="'MyriadPro-Regular'" font-size="8">M2 invades the lamina propria.</tspan><tspan x="0" y="86.4" font-family="'MyriadPro-Regular'" font-size="8">M3 invades into but not through the muscularis mucosa.</tspan><tspan x="0" y="96" font-family="'MyriadPro-Regular'" font-size="8">M1 tumors correspond to the Tis stage in the AJCC stage </tspan><tspan x="0" y="105.6" font-family="'MyriadPro-Regular'" font-size="8">definition, while both M2 and M3 tumors would be </tspan><tspan x="0" y="115.2" font-family="'MyriadPro-Regular'" font-size="8">considered T1a lesions.</tspan></text>
<rect x="328.527" y="4.938" fill="none" width="339.14" height="33.447"/>
<text transform="matrix(1 0 0 1 328.5273 21.9775)" font-family="'MyriadPro-BoldIt'" font-size="24">Superficial Oesophageal Cancer</text>
</svg>
